Controversies in the management of gastrointestinal stromal tumors
Major advances in the medical treatment of gastrointestinal tumors (GISTs) have improved survival for both patients with advanced disease and those diagnosed with high-risk primary tumors. The Consensus approaches to best practice management of gastrointestinal stromal tumors, published in this journal in 2008, provided guidance for the management of GIST to both clinicians and regulatory authorities. Since then, clinical trials have demonstrated the benefit of adjuvant imatinib in high-risk...[Show more]
|Collections||ANU Research Publications|
|Source:||Asia-Pacific Journal of Clinical Oncology|
|01_Yip_Controversies_in_the_2014.pdf||138.62 kB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.